The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)

Introduction: The aim of this study was to examine the role of human papillomavirus testing in the follow-up after treatment for CIN, as a prognostic sign for residual/recurrent cervical precancerous lesions. Methods: A hospital-based analysis was performed on 460 patients previously treated for CIN...

Full description

Bibliographic Details
Main Authors: Goran Dimitrov, Elena Dzikova, Gligor Dimitrov, Saso Panov, Irena Aleksioska, Gjorgji Babusku
Format: Article
Language:English
Published: University of Sarajevo 2013-09-01
Series:Journal of Health Sciences
Subjects:
HPV
Online Access:https://www.jhsci.ba/ojs/index.php/jhsci/article/view/111
id doaj-ab4deac98a1e4cc485ba0786bce82d80
record_format Article
spelling doaj-ab4deac98a1e4cc485ba0786bce82d802020-11-25T02:51:25ZengUniversity of SarajevoJournal of Health Sciences 2232-75761986-80492013-09-013210.17532/jhsci.2013.7562The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)Goran Dimitrov0Elena Dzikova1Gligor Dimitrov2Saso Panov3Irena Aleksioska4Gjorgji Babusku5University Clinic for Gynecology and Obstetrics, Ss. Cyril and Methodius University, Vod-njanska Street No.17 , 1000 Skopje,Republic of MacedoniaUniversity Clinic for Gynecology and Obstetrics, Ss. Cyril and Methodius University, Vod-njanska Street No.17 , 1000 Skopje,Republic of MacedoniaGeneral Hospital Remedika, 16-ta Makedonska brigada Street No.18, 1000 Skopje, Republic of MacedoniaInstitute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje,Republic of MacedoniaUniversity Clinic for Gynecology and Obstetrics, Ss. Cyril and Methodius University, Vod-njanska Street No.17 , 1000 Skopje,Republic of MacedoniaGeneral Hospital Remedika, 16-ta Makedonska brigada Street No.18, 1000 Skopje, Republic of MacedoniaIntroduction: The aim of this study was to examine the role of human papillomavirus testing in the follow-up after treatment for CIN, as a prognostic sign for residual/recurrent cervical precancerous lesions. Methods: A hospital-based analysis was performed on 460 patients previously treated for CIN with cold knife conization, at the University Clinic for Gynecology and Obstetrics and General Hospital Remedika, in Skopje, Republic of Macedonia, in a period of 3 years. The patients were followed-up with HPV testing in addition to cytology, colposcopy and/or biopsy. The first after treatment HPV testing was performed 8 months after cold knife conization, proceeded by follow-up within 24 months after treatment, at 4 months intervals. Results: Among 460 treated patients, at the fi rst HPV and cytologic testing, 8 months after treat-ment, 69 (15%) were HPV+, and 391 (85%) HPV negative. From the 69 HPV+ patients, 41 (59.4%) were with cytologic abnormalities and 28 (40.6%) without abnormalities. 12 months after treatment, the number of HPV+ patients developing cytologic abnormalities raised to 45/70 (64.29%). Within the 24 months after treatment, the number of patients who had recurrent/ residual CIN from the HPV+ patients reached 50/71 (70.42%); which was 10.87% from all 460 treated patients. Conclusion: Persistence or clearance of HPV especially 8 months after treatment even in patients with normal cytology, is an early valid prognostic marker of treatment failure, and is more accurate than cytology at the same follow-up intervals.https://www.jhsci.ba/ojs/index.php/jhsci/article/view/111human papillomavirusuterine cervix carcinomaHPVcervical intraepithelial neoplasia
collection DOAJ
language English
format Article
sources DOAJ
author Goran Dimitrov
Elena Dzikova
Gligor Dimitrov
Saso Panov
Irena Aleksioska
Gjorgji Babusku
spellingShingle Goran Dimitrov
Elena Dzikova
Gligor Dimitrov
Saso Panov
Irena Aleksioska
Gjorgji Babusku
The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
Journal of Health Sciences
human papillomavirus
uterine cervix carcinoma
HPV
cervical intraepithelial neoplasia
author_facet Goran Dimitrov
Elena Dzikova
Gligor Dimitrov
Saso Panov
Irena Aleksioska
Gjorgji Babusku
author_sort Goran Dimitrov
title The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
title_short The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
title_full The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
title_fullStr The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
title_full_unstemmed The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
title_sort role of human papillomavirus (hpv) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (cin)
publisher University of Sarajevo
series Journal of Health Sciences
issn 2232-7576
1986-8049
publishDate 2013-09-01
description Introduction: The aim of this study was to examine the role of human papillomavirus testing in the follow-up after treatment for CIN, as a prognostic sign for residual/recurrent cervical precancerous lesions. Methods: A hospital-based analysis was performed on 460 patients previously treated for CIN with cold knife conization, at the University Clinic for Gynecology and Obstetrics and General Hospital Remedika, in Skopje, Republic of Macedonia, in a period of 3 years. The patients were followed-up with HPV testing in addition to cytology, colposcopy and/or biopsy. The first after treatment HPV testing was performed 8 months after cold knife conization, proceeded by follow-up within 24 months after treatment, at 4 months intervals. Results: Among 460 treated patients, at the fi rst HPV and cytologic testing, 8 months after treat-ment, 69 (15%) were HPV+, and 391 (85%) HPV negative. From the 69 HPV+ patients, 41 (59.4%) were with cytologic abnormalities and 28 (40.6%) without abnormalities. 12 months after treatment, the number of HPV+ patients developing cytologic abnormalities raised to 45/70 (64.29%). Within the 24 months after treatment, the number of patients who had recurrent/ residual CIN from the HPV+ patients reached 50/71 (70.42%); which was 10.87% from all 460 treated patients. Conclusion: Persistence or clearance of HPV especially 8 months after treatment even in patients with normal cytology, is an early valid prognostic marker of treatment failure, and is more accurate than cytology at the same follow-up intervals.
topic human papillomavirus
uterine cervix carcinoma
HPV
cervical intraepithelial neoplasia
url https://www.jhsci.ba/ojs/index.php/jhsci/article/view/111
work_keys_str_mv AT gorandimitrov theroleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT elenadzikova theroleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT gligordimitrov theroleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT sasopanov theroleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT irenaaleksioska theroleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT gjorgjibabusku theroleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT gorandimitrov roleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT elenadzikova roleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT gligordimitrov roleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT sasopanov roleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT irenaaleksioska roleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
AT gjorgjibabusku roleofhumanpapillomavirushpvtestinginthefollowupofpatientsaftertreatmentforcervicalintraepithelialneoplasiacin
_version_ 1724734733787594752